Accelerating Therapeutic Antibody Development: Discover Our Cutting-Edge CHO Expression Technology

Recent advances in recombinant antibody technology have facilitated the development of diverse antibody formats. However, achieving high expression and production levels remains a significant challenge. The CHO cell system is widely employed for recombinant antibody expression, with efficient expression and product quality influenced by factors such as genetic engineering of antibody sequences, optimization of expression vectors, and host cell characteristics.

As a leading provider of comprehensive recombinant protein and antibody services across various expression systems, GenScript is committed to partnering with scientists worldwide to accelerate scientific discovery. Our proprietary GenSmart™ Codon Optimization and newly launched TurboCHO™ expression platform ensure rapid delivery of high-yield, high-purity products in a flexible, cost-effective manner, minimizing time to market. Here, we explore how these innovations can advance your research and therapeutic development efforts.

During the webinar, we will cover the following topics:

Comprehensive Service: GenScript offers end-to-end solutions from gene synthesis to antibody expression, ensuring Turbo Fast Delivery and Competitive Cost.

Cutting-Edge Technologies: Utilizing fully automated liquid handling and QR-code tracking systems, along with AI-powered codon optimization and advanced self-developed CHO expression platforms.

In this webinar, you will learn

Webinar Details

  • Title: Accelerating Therapeutic Antibody Development: Discover Our Cutting-Edge CHO Expression Technology
  • Date: July 18th , 2024
  • Time: 15:00PM KST (GMP +9)
Dr. Yerim Kwon Dr. Yerim Kwon

Field Application Scientist, APAC region

Dr. Yerim Kwon joined GenScript in October 2023 as a Field Application Scientist, focusing on molecular biology, mRNA, and gene editing services. During her doctoral and postdoctoral research, she specialized in studying gene regulation pathways in response to environmental stress and RNA silencing. Her experience includes investigating RNA stability factors and post-translational regulation of RNA silencing pathways. Now, at GenScript, she applies her expertise to provide top-notch service to our clients.

Speaker-related Webinars